tiprankstipranks
Advertisement
Advertisement
Artrya advances U.S. Salix rollout and readies coronary flow module for FDA submission
PremiumCompany AnnouncementsArtrya advances U.S. Salix rollout and readies coronary flow module for FDA submission
2M ago
Artrya Director Increases Shareholding Through $500,000 Option Exercise
Premium
Company Announcements
Artrya Director Increases Shareholding Through $500,000 Option Exercise
2M ago
Artrya seeks ASX quotation for 500,000 new ordinary shares
Premium
Company Announcements
Artrya seeks ASX quotation for 500,000 new ordinary shares
2M ago
Artrya reports lapse of 10,000 performance rights
PremiumCompany AnnouncementsArtrya reports lapse of 10,000 performance rights
3M ago
Artrya launches non-deal roadshow ahead of Bell Potter healthcare showcase
Premium
Company Announcements
Artrya launches non-deal roadshow ahead of Bell Potter healthcare showcase
4M ago
S&P Dow Jones Indices Unveils March 2026 S&P/ASX Index Rebalance
Premium
Company Announcements
S&P Dow Jones Indices Unveils March 2026 S&P/ASX Index Rebalance
4M ago
Artrya Names Interim CFO as It Bolsters Leadership for Next Growth Phase
PremiumCompany AnnouncementsArtrya Names Interim CFO as It Bolsters Leadership for Next Growth Phase
5M ago
Artrya Secures Third U.S. Customer as Cone Health Adopts Salix AI Cardiac Platform
Premium
Company Announcements
Artrya Secures Third U.S. Customer as Cone Health Adopts Salix AI Cardiac Platform
6M ago
Artrya Limited Achieves First U.S. Revenue with Salix® Coronary Plaque Module
Premium
Company Announcements
Artrya Limited Achieves First U.S. Revenue with Salix® Coronary Plaque Module
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100